ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

(+)-Lariciresinol → (+)-Pinoresinol (+)-Lariciresinol

HRID 988076
印刷

反応式

HRID 988076 の反応式
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C@H:10]2[O:17][CH2:16][C@H:15]3[C@@H:11]2[CH2:12][O:13][C@H:14]3[C:18]2[CH:19]=[CH:20][C:21]([OH:26])=[C:22]([O:24][CH3:25])[CH:23]=2)[CH:6]=[CH:7][C:8]=1[OH:9].[CH3:27][O:28][C:29]1[CH:30]=[C:31]([CH2:36][C@@H:37]2[C@H:41]([CH2:42][OH:43])[C@@H:40]([C:44]3[CH:45]=[CH:46][C:47]([OH:52])=[C:48]([O:50][CH3:51])[CH:49]=3)[O:39][CH2:38]2)[CH:32]=[CH:33][C:34]=1[OH:35]>CO>[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C@@H:10]2[O:17][CH2:16][C@@H:15]3[C@H:11]2[CH2:12][O:13][C@H:14]3[C:18]2[CH:19]=[CH:20][C:21]([OH:26])=[C:22]([O:24][CH3:25])[CH:23]=2)[CH:6]=[CH:7][C:8]=1[OH:9].[CH3:27][O:28][C:29]1[CH:30]=[C:31]([CH2:36][C@@H:37]2[C@H:41]([CH2:42][OH:43])[C@@H:40]([C:44]3[CH:45]=[CH:46][C:47]([OH:52])=[C:48]([O:50][CH3:51])[CH:49]=3)[O:39][CH2:38]2)[CH:32]=[CH:33][C:34]=1[OH:35]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 332427(+)-LariciresinolHCID 637584Epipinoresinol2 回

生成物 1

HCID 131722472(+)-Pinoresinol (+)-Lariciresinol

試薬・触媒・溶媒 1

HCID 887Methanol溶媒

反応条件

温度
30 °C

実験手順

Enzyme Assays. Pinoresinol and lariciresinol reductase activities were assayed by monitoring the formation of [3H]lariciresinol and [3H]secoisolariciresinol as set forth in Example 8, with the following modifications. Briefly, each assay for pinoresinol reductase activity consisted of (±)-pinoresinols (5 mM in MeOH, 20 μl) and the enzyme preparation (i.e., total protein extract from E. coli, 210 μl). The enzymatic reaction was initiated by addition of [4R-3H]NADPH (10 mM, 6.79 kBq/mmol in distilled H2O, 20 μl). After 3 hour incubation at 30° C. with shaking, the assay mixture was extracted with EtOAc (500 μl) containing (±)-lariciresinols (20 μg) and (±)-secoisolariciresinols (20 μg) as radiochemical carriers. After centrifugation (13,800×g, 5 min), the EtOAc solubles were removed and the extraction procedure was repeated. For each assay, the EtOAc solubles were combined with an aliquot (100 μl) removed for determination of its radioactivity using liquid scintillation counting. The remainder of the combined EtOAc solubles was evaporated to dryness in vacuo, reconstituted in MeOH/H2O (30:70, 100 μl) and subjected to reversed phase and chiral column HPLC.

後処理

  1. customthe enzyme preparation (i.e., total protein extract from E. coli, 210 μl)
  2. customThe enzymatic reaction
  3. extractionthe assay mixture was extracted with EtOAc (500 μl)
  4. additioncontaining (±)-lariciresinols (20 μg) and (±)-secoisolariciresinols (20 μg) as radiochemical carriers
  5. customAfter centrifugation (13,800×g, 5 min), the EtOAc solubles were removed
  6. extractionthe extraction procedure
  7. customremoved for determination of its radioactivity
  8. customThe remainder of the combined EtOAc solubles was evaporated to dryness in vacuo

出典と根拠

ORDレコード
ord-3355eda6ba77466bab8234bb86e7bfad
出典データセット
uspto-grants-2003_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06635459B1

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート